At the 2025 Community Oncology Alliance Annual Meeting, group purchasing organisation AllyGPO and specialty distributor BioCareSD showcased their strategic partnership aimed at improving specialty drug management for independent oncology practices.

The alliance combines AllyGPO's data-driven technology with BioCareSD's modern distribution platform to enhance operational efficiency and patient care delivery.

AllyGPO's specialty drug management platform, AllyIQ, is tailored exclusively for community oncology. It features role-based workflows, a smart drug cabinet and integrated business intelligence tools to improve inventory control and contract performance.

Currently in use nationwide, AllyIQ helps practices optimise operations, enabling clinicians to dedicate more time to patient care. BioCareSD complements this with a temperature-controlled distribution system that ensures reliable, sustainable delivery of cancer therapies.

Their cloud-native platforms, built without legacy infrastructure constraints, allow both companies to rapidly adapt to evolving practice needs. Seamless integration with electronic health records and practice management systems delivers timely insights on drug usage and economics.

This collaboration reflects a commitment to empowering oncology practices with efficient, future-ready tools, the two companies said.